Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858) has released an update.
Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced an update on the expected timeline and changes to certain projects funded by its A Share Offering proceeds, which were originally detailed in past regulatory announcements and circulars. The adjustments, which include changes to the main implementation entities and locations, have been approved by the company’s board and are pending shareholder approval at an upcoming extraordinary general meeting. The company successfully raised over 1.14 billion RMB through its public issuance of 38,428,000 shares, with net proceeds of approximately 1.07 billion RMB after expenses, which are now securely held in a supervised special account.
For further insights into HK:1858 stock, check out TipRanks’ Stock Analysis page.